Search clinical trials for: valsartan plus hydrochlorothiazide

Total 5584 results

Novartis

Completed

The VALIDATE Study of Valsartan for Patients With Early Stage Heart Failure

Hypertension | Congestive Heart Failure
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Lisinopril and Hydrochlorothiazide Tablets (20+25) mg Under Fed Conditions

Fed

India
Novartis

Completed

Diva - The Effects Of 12 Weeks Of Treatment With High Dose Valsartan (320 Mg) To Amlodipine On Endothelial Function In Hypertensive Subjects With The Metabolic Syndrome

Hypertension | Metabolic Syndrome
Josep M Cruzado

Recruiting

Renin Angiotensin System Blockade in Renal Transplant Patients With Presence of PECs in Urine

Chronic Kidney Allograft Nephropathy

Spain
Korea University Anam Hospital

Completed

Comparison of Effects of Telmisartan and Valsartan on Neointima Volume in Diabetes

Coronary Artery Disease | Hypertension | Diabetes

Korea, Republic of
Takeda

Completed

Safety and Tolerability of Azilsartan Medoxomil Plus Chlorthalidone Compared to Olmesartan Medoxomil Plus Hydrochlorothiazide in Participants With Essential Hypertension

Essential Hypertension

Netherlands, Austria, Germany, Poland, United Kingdom
University Medical Center Groningen

Not yet recruiting

HYDROchlorothiazide to PROTECT Polycystic Kidney Disease Patients and Improve Their Quality of Life (HYDRO-PROTECT)

ADPKD

Netherlands, United Kingdom, Belgium, Germany, France, Spain
Ranbaxy Laboratories Limited
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Hydrochlorothiazide 50mg Tablets Under Fasting Conditions

Healthy
Boehringer Ingelheim

Completed

PROBE Parallel 6-week Treatment Comparing Telmisartan/Hydrochlorothiazide (HCT) (40/12.5 or 80/12.5) With Losartan/HCT (50/12.5) Using Ambulatory Blood Pressure Monitoring (ABPM)

Hypertension

United States
Boehringer Ingelheim

Completed

Telmisartan With or Without Hydrochlorothiazide in Patients With Mild-to-moderate Hypertension

Hypertension
Advanced Accelerator Applications

Recruiting

[177Lu]-NeoB in Patients With Advanced Solid Tumors and With [68Ga]-NeoB Lesion Uptake (NeoRay)

Neoplasms

United States, Netherlands, Austria, Spain, France, Germany, United Kingdom
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Lisinopril and Hydrochlorothiazide Tablets (20+25) mg Under Fasting Conditions

Fasting

India
West China Hospital

Not yet recruiting

The Effects of Sacubitril-Valsartan vs Enalapril on Left Ventricular Remodeling in ST-elevation Myocardial Infarction (PERI-STEMI)

STEMI

China
The Cleveland Clinic

Withdrawn

Comparison of ARNI to Alternate Oral Vasodilator Therapies in Patients With Low Cardiac Output (PARAVLO-HF)

Cardiogenic Shock

United States
Takeda

Completed

Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Moderate to Severe Hypertension.

Essential Hypertension

United States, Canada
The University of Hong Kong

Recruiting

Exercise-induced Erythropoiesis: the Mechanistic of Angiotensin II

Exercise Physiology

Hong Kong
IlDong Pharmaceutical Co Ltd

Unknown

A Bioequivalence Study Comparing Cilnidipine/Valsartan Combination Tablet With Coadministration of Cilnidipine and Valsartan

Healthy Volunteers

Korea, Republic of
Novartis

Completed

Clinical Trial To Evaluate The Effect Of Valsartan On Insulin Sensitivity In Subjects With Impaired Glucose Tolerance

Hypertension | Impaired Glucose Tolerance
Hallym University Medical Center

Unknown

Valsartan Efficacy on Modest Blood Pressure Reduction in Acute Ischemic Stroke (VENTURE)

Acute Ischemic Stroke

Korea, Republic of
Astellas Pharma Inc

Completed

A Study to Assess the Effect of ASP1585 on Pharmacokinetics of Valsartan in Healthy Volunteers

Healthy | Pharmacokinetics of Valsartan

Japan
Kitasato University
Yokohama City University Medical Center; St. Marianna University School of... and other collaborators

Unknown

Intensive Medical Treatment for Nephropathy Caused by Type 2 Diabetes With Hypertension

Hypertension | Type 2 Diabetes Mellitus

Japan
Novartis

Completed

VALID: Study to Compare the Reduction of Predialysis Systolic Blood Pressure With Valsartan Compared to Irbesartan in Patients With Mild to Moderate Hypertension on Long-term Hemodialysis

Hypertension

Switzerland, Germany
Boehringer Ingelheim

Completed

3 x 3 Factorial Trial of Telmisartan and Hydrochlorothiazide in Patients With Essential Hypertension

Hypertension

Japan
University of Sao Paulo

Unknown

Safety and Efficacy of Hydrochlorothiazide in the Treatment of Hypernatremia in Critically Ill Patients (HYDRA)

Critical Illness | Hypernatremia

Brazil
University of New Mexico
University of Pittsburgh; Dialysis Clinic, Inc.

Terminated

Epithelial Sodium Channel (ENaC) as a Novel Mechanism for Hypertension and Volume Expansion in Type 2 Diabetes

Hypertension | Proteinuria | Type II Diabetes

United States
Gachon University Gil Medical Center

Completed

Additive Effects of Pravastatin and Valsartan

Hypertension | High Cholesterol

Korea, Republic of
Novartis Pharmaceuticals

Completed

Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MI (PARADISE-MI)

Acute Myocardial Infarction

China, United States, South Africa, Italy, Spain, Croatia, Czechia, Hungary, Romania, Taiwan, Belgium, Germany, Netherlands, Austria, Denmark, United Kingdom, Thailand, Argentina, Israel, Australia, Bulgaria, France, Greece, Russian Federation and more
University of Alberta

Completed

Glutamine to Improve Outcomes in Cardiac Surgery (GLADIATOR)

Nosocomial Infection

Canada
Qure Healthcare, LLC
Lineagen

Completed

Establishing the Clinical Utility of First StepDx PLUS and NextStepDx PLUS Study

Intellectual Disability | Developmental Delay

United States
Boehringer Ingelheim

Completed

Telmisartan Plus Hydrochlorothiazide in Subjects With Mild-to-moderate Hypertension Who Failed to Respond to Telmisartan Monotherapy

Hypertension
Boehringer Ingelheim

Completed

Telmisartan Tab Hypertension

Hypertension
Novartis Pharmaceuticals

Terminated

To Study the Effects of Aliskiren on Albuminuria and Various Biomarkers in Patients With Nephropathy (ARIA)

Non-diabetic Nephropathy

Netherlands
Universidade do Porto
Rede de Investigação em Saúde (RISE), Laboratório Associado; Faculty of Medicine... and other collaborators

Recruiting

Initiation of ARNi and SGLT2i in Patients With HFrEF (INITIATE)

Heart Failure With Reduced Ejection Fraction

Portugal
Italian Society of Cardiology
Federico II University; University Of Perugia; University of Messina; Azienda Ospedaliero-Universitaria... and other collaborators

Completed

Role of Sacubitril/Valsartan in the Improvement of Heart Failure With Reduced Ejection Fraction

Left Ventricular Dysfunction | Ventricular Remodeling | Heart Failure, Left Sided

Italy
University of Washington
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Repurposing Valsartan May Protect Against Pulmonary Hypertension (REVAMP-PH)

Pulmonary Arterial Hypertension | Right Ventricular Dysfunction | Right Heart Failure | Pulmonary Vascular Disorder

United States
Boehringer Ingelheim
Bayer; GlaxoSmithKline

Completed

Telmisartan vs. Valsartan in Patients With Mild to Moderate Hypertension Following a Missed Dose

Hypertension

United States, Canada
Novartis

Completed

Comparative Study of Valsartan and Amlodipine Versus Amlodipine Alone in Hypertension

Hypertension

Switzerland
HeartDrug Research LLC
Novartis

Unknown

Effects of Valsartan and Aliskiren on Hemostatic Indices in Hypertensive Diabetics

Diabetes Mellitus

United States
The First Affiliated Hospital of Dalian Medical...
Huazhong University of Science and Technology; LinkDoc Technology (Beijing)...

Recruiting

Huaiqihuang Granule in CKD Stage 3 Primary Glomerulonephritis

Renal Insufficiency, Chronic

China
Novartis Pharmaceuticals

Active, not recruiting

Efficacy and Safety of Sacubitril/Valsartan Compared With Enalapril on Morbidity, Mortality, and NT-proBNP Change in Patients With CCC (PARACHUTE-HF)

Heart Failure | Chagas Disease

Brazil, Argentina, Mexico, Colombia
Jiangsu HengRui Medicine Co., Ltd.

Completed

Safety and Effect Study of SHR0532 (Drug Code) Tablets in Patients With Mild Hypertension

Hypertension

China
University of New Mexico

Unknown

A Comparison of Hydrochlorothiazide and Metolazone in Combination With Furosemide in Congestive Heart Failure Patients

Congestive Heart Failure

United States
University of South Carolina
American Cancer Society, Inc.

Completed

Peers Promoting Exercise Adoption and Maintenance Among Cancer Survivors

Breast Cancer

United States
Organon and Co

Completed

Antihypertensive Efficacy and Safety of Approved Drugs in Japanese Patients With Essential Hypertension (Banyu Study)(0954A-302)

Hypertension
John Paul II Hospital, Krakow

Not yet recruiting

The Effect of Sacubitril/Valsartan Versus Ramipril on Left Ventricular Function and Remodeling in Patients With Ischemic Heart Failure With Mid-range Ejection Fraction (CRACOVIA-HF)

Heart Failure With Moderately Reduced Ejection Fraction
Clinical Hospital Heliodor Swiecicki of the Medical...
Medical University of Silesia; Medical University of Gdansk; Medical University... and other collaborators

Recruiting

Pulmonary REsistance Modification Under Treatment With Sacubitril/valsartaN in paTients With Heart Failure With Reduced Ejection Fraction (PRESENT-HF)

Heart Failure

Poland
Brigham and Women's Hospital

Completed

Replication of the PARADIGM-HF Heart Failure Trial in Healthcare Claims Data.

Heart Failure

United States
Jiangsu HengRui Medicine Co., Ltd.

Completed

Drug-Drug Interaction Study Between Henagliflozin Proline and Hydrochlorothiazide

Diabetes in Adults

China
Medical University of Silesia
Polpharma Pharmaceutical Company

Terminated

Valsartan to Prevent Left Ventricle Remodeling in Pacemaker Patients

First Time Dual Chamber Pacemaker Implantation

Poland
Intermountain Health Care, Inc.
Novartis

Terminated

The Use of DIOVAN to Reduce Post-Cardioversion Recurrence of Atrial Fibrillation Trial (the DRAFT Trial)

Atrial Fibrillation

United States

3

Subscribe